Fundz

Vedanta Biosciences, Inc. reported raising $8 Million in an initial SEC Form D filing, from an offering of $16.6 Million

PRIVATESep 19, 2019$8M of $16.6M raised

Amount Raised

$8 Million

$8 Million sold, per SEC Form D (first sale Sep 19, 2019)

Round Type

Venture

CambridgeHealthcare

Quick answer

VEDANTA BIOSCIENCES, INC. raised $8 Million in a funding round, dated September 19, 2019. VEDANTA BIOSCIENCES, INC. is based in Cambridge, Maryland, United States.

How much did VEDANTA BIOSCIENCES, INC. raise?
VEDANTA BIOSCIENCES, INC. raised $8 Million in a funding round on September 19, 2019.
What does VEDANTA BIOSCIENCES, INC. do?
Vedanta Biosciences is developing a class of drugs that work by modulating the human microbiome.
Where is VEDANTA BIOSCIENCES, INC. based and how big is it?
VEDANTA BIOSCIENCES, INC. is based in Cambridge, Maryland, United States. Fundz records about 75 employees.
Who are the decision-makers at VEDANTA BIOSCIENCES, INC?
Fundz holds 2 contacts at VEDANTA BIOSCIENCES, INC., including the Executive Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as VEDANTA BIOSCIENCES, INC. that raised within 45 days of this round, from Fundz verified event records.

  • T3D Therapeutics, Inc. raised $15M on November 1, 2019.
  • MindImmune Therapeutics raised $750K on November 1, 2019.
  • Brave Care raised $5.2M on November 1, 2019.
  • Variant Pharmaceuticals, Inc. raised $1.3M (Seed) on November 1, 2019.
  • Presidium Health Corp raised $3.6M (Seed) on November 1, 2019.
  • Protect3d raised $30K (Pre-Seed) on November 1, 2019.

Who to call at VEDANTA BIOSCIENCES, INC., and when

A new round usually means VEDANTA BIOSCIENCES, INC. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day VEDANTA BIOSCIENCES, INC. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at VEDANTA BIOSCIENCES, INC., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at VEDANTA BIOSCIENCES, INC.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

VEDANTA BIOSCIENCES, INC.

Location

19 BLACKSTONE STREET, THIRD FLOOR

Cambridge, Maryland, United States

About

Vedanta Biosciences is developing a class of drugs that work by modulating the human microbiome.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment VEDANTA BIOSCIENCES, INC. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsMark M., Executive Officer hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for VEDANTA BIOSCIENCES, INC.'s next move

See what Strategic adds

VEDANTA BIOSCIENCES, INC. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.